Insider Transactions in Q1 2023 at Mirati Therapeutics, Inc. (MRTX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 20
2023
|
Craig A Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
4,444
+29.81%
|
-
|
|
Jan 20
2023
|
Charles M Baum Founder, President, and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,444
+2.5%
|
-
|
|
Jan 20
2023
|
Aaron I. Davis |
BUY
Grant, award, or other acquisition
|
Direct |
4,444
+8.55%
|
-
|
|
Jan 20
2023
|
Faheem Hasnain |
BUY
Grant, award, or other acquisition
|
Direct |
6,333
+29.62%
|
-
|
|
Jan 20
2023
|
Julie M Cherrington |
BUY
Grant, award, or other acquisition
|
Direct |
4,444
+50.0%
|
-
|
|
Jan 20
2023
|
Maria E Martinez |
BUY
Grant, award, or other acquisition
|
Direct |
4,444
+29.81%
|
-
|
|
Jan 20
2023
|
Henry J Fuchs |
BUY
Grant, award, or other acquisition
|
Direct |
4,444
+29.81%
|
-
|
|
Jan 20
2023
|
Laurie Stelzer Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,864
+24.09%
|
-
|
|
Jan 20
2023
|
Bruce L A Carter |
BUY
Grant, award, or other acquisition
|
Direct |
4,444
+29.81%
|
-
|
|
Jan 20
2023
|
Benjamin Hickey EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,394
+30.33%
|
-
|
|
Jan 20
2023
|
David D. Meek Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
89,379
+37.16%
|
-
|
|
Jan 20
2023
|
Jamie Christensen EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,864
+17.72%
|
-
|
|
Jan 20
2023
|
Shalini Sharp |
BUY
Grant, award, or other acquisition
|
Direct |
4,444
+32.07%
|
-
|
|
Jan 18
2023
|
Julie M Cherrington |
SELL
Open market or private sale
|
Direct |
2,546
-100.0%
|
$112,024
$44.66 P/Share
|
|
Jan 17
2023
|
Benjamin Hickey EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,566
-1.62%
|
$65,772
$42.38 P/Share
|
|
Jan 17
2023
|
Jamie Christensen EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,245
-1.13%
|
$94,290
$42.38 P/Share
|
|
Jan 17
2023
|
David D. Meek Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,179
-4.89%
|
$133,518
$42.38 P/Share
|
|
Jan 09
2023
|
Benjamin Hickey EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,088
-4.1%
|
$93,960
$45.37 P/Share
|
|
Jan 04
2023
|
Jamie Christensen EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,949
-1.91%
|
$89,654
$46.6 P/Share
|
|
Jan 04
2023
|
Charles M Baum Founder, President, and CEO |
SELL
Open market or private sale
|
Direct |
3,648
-2.12%
|
$167,808
$46.6 P/Share
|